Why Lineage Cell Therapeutics, Inc. (LCTX) stock is Popping High Today?
Lineage Cell Therapeutics, Inc. (LCTX) stock reported additional cases of retinal tissue restoration in its Phase 1/2a study of lead product candidate OpRegen after which the LCTX stock happened to be green after declining in the previous trading session and LCTX stock price saw a push of 10.55% to reach $2.62 a share at the […]
